Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoliflodacin vs Ceftriaxone + Azithromycin for Uncomplicated Gonorrhoea
NCT03959527Phase 3Completed
- Sponsor
- GARDP
- Start
- Nov 2019
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of zoliflodacin in gonorrhea, sponsored by GARDP. Started Nov 2019; status: completed.
02
Drugs
zoliflodacin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT03959527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03959527.